Investment Thesis
The stock of the Deckers Outdoor Corporation (NASDAQ:DECK) is best positioned to return over 22% to its shareholders in the short-term investment horizon, although long-term prospects are much brighter based on the improving company’s business prospects. Despite its excellent performance in the last one year (over 30% run-up), DECK is still undervalued and offers a fair price of $72.
Click to enlarge
Source: Bloomberg
Business Analysis
The last couple of years have been a real challenge for the consumer goods companies, particularly, the apparel industry due to the restrictive consumer spending and macroeconomic headwinds. Companies’ margins squeezed resulting from low growth in revenues and higher-than-average operating expenditures due to a certain portion of fixed operating expenses in the cost structure. DECK is one of those companies that faced a tough business environment in last few quarters, therefore, observed decreased operating margins.
Top 10 Undervalued Stocks For 2018: Frontline Ltd.(FRO)
Advisors’ Opinion:
- [By Rich Smith]
So what is it that’s supporting DHT’s stock price in the face of sliding shipping rates for crude oil, retreating revenue, and plunging profits? Well, for one thing, rival tanker companyFrontline (NYSE:FRO) made an unsolicited bid to acquire DHT last week, offering to pay $475 million for the company. (DHT is currently valued at $460 million.)
- [By Lisa Levin]
Wednesday afternoon, the energy shares surged 1.23 percent. Meanwhile, top gainers in the sector included Frontline Ltd. (NYSE: FRO), up 5 percent, and JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO), up 6 percent.
- [By Shanthi Rexaline]
Frontline Ltd. (NYSE: FRO) is projected to post a loss in the second quarter, translating to a zero dividend, Credit Suisse said in a Tuesday note. Notwithstanding the negative opinion, the shares of the company were up in reaction to the possibility of a deal being struck.
Top 10 Undervalued Stocks For 2018: Akebia Therapeutics, Inc.(AKBA)
Advisors’ Opinion:
- [By Todd Campbell]
After inking an expanded deal withOtsuka Pharmaceutical on its midstage anemia drug, shares ofAkebia Therapeutics (NASDAQ:AKBA)skyrocketed 33.4% today.
- [By Alex McGuire]
As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…
Pharmaceutical Stock Current Share Price April 2017 Gain
Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%
The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.
- [By Lisa Levin]
Shares of Akebia Therapeutics Inc (NASDAQ: AKBA) got a boost, shooting up 39 percent to $13.04. Akebia Therapeutics and Otsuka disclosed that they have expanded relationship with collaboration to develop and commercialize Vadadustat in Europe, China and other territories.
Top 10 Undervalued Stocks For 2018: Coca-Cola Enterprises, Inc.(CCE)
Advisors’ Opinion:
- [By Lisa Levin] Related LOV Match Group And Spark Networks: A Valentine's Day Case Study 20 Biggest Mid-Day Losers For Thursday
Related VKTX 15 Biggest Mid-Day Losers For Tuesday 18 Biggest Mid-Day Losers For Wednesday Companies Reporting Before The Bell
Canadian Solar Inc. (NASDAQ: CSIQ) is expected to report its quarterly earnings at $0.32 per share on revenue of $690.27 million.
General Mills, Inc. (NYSE: GIS) is projected to report its quarterly earnings at $0.71 per share on revenue of $3.84 billion.
Coca-Cola European Partners Plc (NYSE: CCE) is estimated to report its quarterly earnings at $0.45 per share on revenue of $2.72 billion.
Lands' End, Inc. (NASDAQ: LE) is expected to report its quarterly earnings at $0.35 per share on revenue of $459.43 million.
Francesca's Holdings Corp (NASDAQ: FRAN) is estimated to report its quarterly earnings at $0.37 per share on revenue of $145.91 million.
Cheetah Mobile Inc (ADR) (NYSE: CMCM) is projected to report its quarterly earnings at $0.06 per share on revenue of $178.04 million.
Neogen Corporation (NASDAQ: NEOG) is estimated to report its quarterly earnings at $0.27 per share on revenue of $90.05 million.
Lennar Corporation (NYSE: LEN) is projected to post earnings for its first quarter.
Fifth Street Asset Management Inc (NASDAQ: FSAM) is expected to report its quarterly earnings at $0.14 per share on revenue of $25.12 million.
Top 10 Undervalued Stocks For 2018: Thor Industries Inc.(THO)
Advisors’ Opinion:
- [By Peter Graham]
A long term performance chart shows shares of Winnebago Industries recently moving past 2013 highs whilepeersDrew Industries, Inc (NYSE: DW) and Thor Industries, Inc (NYSE: THO) havealso taken off to new highs this year:
- [By Peter Graham]
A long term performance chart shows shares of Winnebago Industries and small cap peer Thor Industries, Inc (NYSE: THO) giving a similar performance with shares taking off last year before stumbling this year while Drew Industries, Inc (NYSE: DW) has mostly underperformed:
- [By WWW.THESTREET.COM]
In his second “Executive Decision” segment, Cramer spoke with Bob Martin, president and CEO of Thor Industries (THO) , a stock that was crushed today, down 9.8%, on a penny-a-share earnings beat with tempered guidance.
- [By Elizabeth Balboa]
Supply could come from any number of industry players, including Winnebago Industries, Inc. (NYSE: WGO), Thor Industries, Inc. (NYSE: THO), Polaris Industries Inc. (NYSE: PII) and Camping World Holdings Inc (NYSE: CWH). However, whether it comes from existing inventory and whether suppliers can meet the demand are yet to be seen.
Top 10 Undervalued Stocks For 2018: Integrated Device Technology, Inc.(IDTI)
Advisors’ Opinion:
- [By Lisa Levin]
T-Mobile US Inc (NYSE: TMUS) reported upbeat earnings for its fourth quarter on Tuesday.
Integrated Device Technology Inc (NASDAQ: IDTI) agreed to acquire GigPeak Inc (NYSE: GIG) for around $250 million in cash.
Charles River Laboratories Intl. Inc (NYSE: CRL) reported better-than-expected profit for its fourth quarter.
Amkor Technology, Inc. (NASDAQ: AMKR) posted downbeat revenue for its fourth quarter and issued a weak outlook for the current quarter. - [By Lisa Levin]
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Analysts are expecting Discovery Communications Inc. (NASDAQ: DISCA) to have earned $0.47 per share on revenue of $1.69 billion in the latest quarter. Discovery Communications shares rose 0.17 percent to $29.08 in after-hours trading.
Analysts expect T-Mobile US Inc (NASDAQ: TMUS) to report
Top 10 Undervalued Stocks For 2018: ConocoPhillips(COP)
Advisors’ Opinion:
- [By WWW.THESTREET.COM]
In the Lightning Round, Cramer was bullish on Salesforce.com (CRM) , Paccar (PCAR) , Cummins (CMI) , ConocoPhillips (COP) , Adobe Systems (ADBE) , Annaly Capital (NLY) and Hewlett Packard Enterprise (HPE) .
- [By Chris Dier-Scalise]
Among the brands being sold were Alcoa Corporation (NYSE: AA) and Ford Motor Company(NYSE: F), which both paid out dividends in December. The financial and oil sectors also experienced a sell-off to finish 2016. Wells Fargo & Co (NYSE: WFC) and Citigroup Inc (NYSE: C) were net sold as each reached new year-to-date highs and investors unloaded ConocoPhillips (NYSE: COP) and Chevron Corporation (NYSE: CVX) as their prices normalized with the rise in the price of oil.
- [By Shanthi Rexaline]
Smaller brethren ConocoPhillips (NYSE: COP) reported an adjusted loss of $0.14 per share compared to the break-even result the Street was forecasting. However, the loss narrowed notably from the $0.95 per share loss reported a year ago.
- [By Spencer Israel]
And these were the most popular sells:
Bristol-Myers Squibb Co(NYSE: BMY)
Pfizer Inc. (NYSE: PFE)
Gilead Sciences, Inc. (NASDAQ: GILD)
ConocoPhillips (NYSE: COP)
Chevron Corporation (NYSE: CVX)
The following chart shows the IMX performance since it's inception at the end of 2012. You can see how it's generally correlated to the broader equities market. - [By Chris Lange]
The number of ConocoPhillips (NYSE: COP) shares short increased to 15.87 million from the previous level of 13.22 million. Shares were trading at $44.10, within a 52-week range of $38.19 to $53.17.
Top 10 Undervalued Stocks For 2018: Tahoe Resources, Inc.(TAHO)
Advisors’ Opinion:
- [By Diane Alter]
Best Silver Stocks to Buy Now, No. 1: Tahoe Resources (NYSE: TAHO) is a Nevada-based silver miner that operates in the Americas. The company primarily produces silver, but also works with copper, gold, lead, zinc, natural gas, and petroleum. On Aug. 10, TAHO reported Q2 earnings per share of $0.19, $0.05 better than expected. Revenue rose 70.6% year over year to $228.3 million. The company recorded half-year production of 11.4 million ounces of silver and 167,168 ounces of gold. Based on operating results during the first six months of 2016, and expectations for the second half of the year, TAHO expects to achieve the top end of its 2016 guidance for silver production. New quarterly filings reveal influential hedge fund Bridgewater Associates took a new position of approximately 200,000 TAHO shares. At $13.89, TAHO is up 60.32% in 2016.
- [By Paul Ausick]
Tahoe Resources Inc. (NYSE: TAHO) dropped about 8.6% Friday, to post a new 52-week low of $7.27 after closing at $7.95 on Thursday. The stock’s 52-week high is $17.01. Volume was approaching double the daily average of around 2.6 million shares. The gold and silver miner reported results last night that missed profit estimates.
Top 10 Undervalued Stocks For 2018: Celestica, Inc.(CLS)
Advisors’ Opinion:
- [By Peter Graham]
A long term performance chart shows shares of mid caps Jabil Circuit and Flextronics International Ltd (NASDAQ: FLEX) along with small capCelestica Inc (NYSE: CLS) and Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newslettersuggestion as the next breakout stock, all performing well recently as the tech stocks they supply outperform:
- [By Peter Graham]
A long term performance chart shows shares of small cap Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newsletter suggestion as the next breakout stock, andmid cap Flextronics International being bigger winners compared with the also good performance of mid cap Jabil Circuit, Inc (NYSE: JBL) and small cap Celestica Inc (NYSE: CLS):
Top 10 Undervalued Stocks For 2018: Female Health Company (The)(FHCO)
Advisors’ Opinion:
- [By Lisa Levin]
Shares of Female Health Co (NASDAQ: FHCO) were down 15 percent to $1.46 as the company reported that it has entered into a merger agreement with Aspen Park Pharma.
Top 10 Undervalued Stocks For 2018: Cytokinetics, Incorporated(CYTK)
Advisors’ Opinion:
- [By Paul Ausick]
Cytokinetics Inc. (NASDAQ: CYTK) dropped about 37% Tuesday to post a new 52-week low of $7.00 after closing at $11.10 on Monday. The 52-week high is $17.20. Volume was around 7 million, about 14 times the daily average of less than 500,000. The company’s ALS drug failed ti meet its endpoint in a phase 3 study.
- [By Chris Lange]
Cytokinetics, Inc. (NASDAQ: CYTK) saw its shares take a massive step back in Tuesdays session after the firm reported negative results for its trial in amyotrophic lateral sclerosis (ALS). Specifically, the firms Phase 3 clinical trial of tirasemtiv did not meet the primary endpoint or any of the secondary endpoints.
- [By Lisa Levin] Gainers
Marathon Patent Group Inc (NASDAQ: MARA) shares surged 30.2 percent to $5.01 after dropping 40.86 percent on Tuesday. Marathon Patent Group filed for sale of 1.85 million shares of common stock by selling stockholders.
Capricor Therapeutics Inc (NASDAQ: CAPR) shares jumped 17.2 percent to $2.25 after the company reported the FDA clearance of Investigational New Drug application for CAP-1002.
Rite Aid Corporation (NYSE: RAD) gained 13.2 percent to $2.15 following 16.5 percent rally on Tuesday.
Photronics, Inc. (NASDAQ: PLAB) shares climbed 11.8 percent to $10.45 after the company reported stronger-than-expected earnings for its fourth quarter.
China Distance Education Hldgs Ltd (ADR) (NYSE: DL) shares surged 11.3 percent to $8.67. China Distance Education reported Q4 profit of $5.9 million on revenue of $41.7 million.
Cytokinetics, Inc. (NASDAQ: CYTK) shares gained 11 percent to $8.05 after falling 7.05 percent on Tuesday.
Ooma Inc (NYSE: OOMA) shares surged 8.5 percent to $10.85 as the company posted strong Q3 results.
Nuance Communications Inc. (NASDAQ: NUAN) climbed 8 percent to $17.12 after the company reported stronger-than-expected results for its fourth quarter on Tuesday.
American Superconductor Corporation (NASDAQ: AMSC) surged 7.8 percent to $3.59 after the company reported $8 million in D-VAR system orders.
Thermon Group Holdings Inc (NYSE: THR) rose 6.3 percent to $24.17. William Blair upgraded Thermon Group from Market Perform to Outperform.
Domino's Pizza, Inc. (NYSE: DPZ) surged 6.1 percent to $182.88. Nomura upgraded Domino's from Neutral to Buy.
Xencor Inc (NASDAQ: XNCR) rose 5.9 percent to $21.17. Cantor Fitzgerald initiated coverage on Xencor with an Overweight rating.
Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 5.1 percent to $2.28 after the company disclosed that it has been granted FDA Fast Track designation for IMO-2125.
Regal Entertainment Group (NYSE: RGC) gained 5.1 percent to - [By Lisa Levin]
Cytokinetics, Inc. (NASDAQ: CYTK) shares dropped 27 percent to $8.12 on the back of negative trial results for its amyotrophic lateral sclerosis, or ALS, treatment candidate tirasemtiv in a late-stage study. The results of the international Phase 3 study showed tiraemtive did not meet the primary endpoint of change from baseline in slow vital capacity, or SVS, evaluated at 24 weeks, as well the secondary endpoints evaluated at 48 weeks.
